Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial

References

• Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000;80:717–66
   PubMed Web of Science ®Google Scholar
• Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie 2000;82:943–53
   PubMed Web of Science ®Google Scholar
• Olver J, Esquenazi A, Fung VS, et al. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. Eur J Neurol 2010;17:57–73
   PubMed Web of Science ®Google Scholar
• Sheean G, Lannin NA, Turner-Stokes L, et al. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol 2010;17:74–93
   PubMed Web of Science ®Google Scholar
• O'Brien CF. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve Suppl 1997;6:S176–80
   PubMedGoogle Scholar
• Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 1997;6:S129–45
   PubMedGoogle Scholar
• Lim EC, Seet RC. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurologica Scandinavica 2008;117:73–84
   PubMed Web of Science ®Google Scholar
• Ross MH, Charness ME, Sudarsky L, Logigian EL. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles. Muscle Nerve 1997;20:593–8
   PubMed Web of Science ®Google Scholar
• Brans JW, de Boer IP, Aramideh M, et al. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 1995;242:529–34
   PubMed Web of Science ®Google Scholar
• Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992;42:878–82
   PubMed Web of Science ®Google Scholar
• Dubinsky RM, Gray CS, Vetere-Overfield B, Koller WC. Electromyographic guidance of botulinum toxin treatment in cervical dystonia. Clin Neuropharmacol 1991;14:262–7
   PubMed Web of Science ®Google Scholar
• Mayer NH, Whyte J, Wannstedt G, Ellis CA. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Arch Phys Med Rehabil 2008;89:982–7
   PubMed Web of Science ®Google Scholar
• Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987;67:206–7
   PubMed Web of Science ®Google Scholar
• Loewen SC, Anderson BA. Predictors of stroke outcome using objective measurement scales. Stroke 1990;21:78–81
   PubMed Web of Science ®Google Scholar
• Monnier G, Parratte B, Tatu L, et al. EMG support in botulinum toxin treatment. Ann Readapt Med Phys 2003;46:380–5
   PubMedGoogle Scholar
• Schroeder AS, Berweck S, Lee SH, Heinen F. Botulinum toxin treatment of children with cerebral palsy -- a short review of different injection techniques. Neurotox Res 2006;9:189–96
   PubMed Web of Science ®Google Scholar
• Molloy FM, Shill HA, Kaelin-Lang A, Karp BI. Accuracy of muscle localization without EMG: implications for treatment of limb dystonia. Neurology 2002;58:805–7
   PubMed Web of Science ®Google Scholar
• Gracies JM, Lugassy M, Weisz DJ, et al. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. Arch Phys Med Rehabil 2009;90:9–16 e2
   PubMed Web of Science ®Google Scholar
• Ward AB, Aguilar M, De Beyl Z, et al. Use of botulinum toxin type A in management of adult spasticity -- a European consensus statement. J Rehabil Med 2003;35:98–9
   PubMed Web of Science ®Google Scholar
• Jankovic J, Schwartz K, Clemence W, et al. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250–6
   PubMed Web of Science ®Google Scholar
• Jankovic J. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve 2001 Nov;24:1568–70
   Google Scholar
• Childers MK. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am 2003;14:781–92
   PubMedGoogle Scholar
• Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psy 1990;53:633–9
   PubMed Web of Science ®Google Scholar
• Jankovic J, Schwartz KS. Use of botulinum toxin in the treatment of hand dystonia. J Hand Surg 1993;18:883–7
   PubMed Web of Science ®Google Scholar
• Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Neurol Sci 2005;26:32–9
   PubMed Web of Science ®Google Scholar
• Johnson GR. Outcome measures of spasticity. Eur J Neurol 2002;9:10–6; discussion 53–61
   PubMed Web of Science ®Google Scholar
• Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Dis Rehabil 2005;27:7–18
   PubMed Web of Science ®Google Scholar